Document is current

Any future updates will be listed below

Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?

Crossref DOI link: https://doi.org/10.1007/s40261-017-0503-6

Published Online: 2017-02-21

Published Print: 2017-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark